documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
125 rows where docket_id = "FDA-2008-N-0567" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 4
- Supporting & Related Material 116
- Notice 7
- Other 1
- Rule 1
agency_id 1
- FDA 125
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2008-N-0567-0167 | FDA | None FDA-2008-N-0567 | Notice of Decision Not To Designate Coccidioidomycosis as an Addition to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act | Notice | General Notice | 2020-07-15T04:00:00Z | 2020 | 7 | 2020-07-15T04:00:00Z | 2020-07-15T13:09:33Z | 2020-15255 | 0 | 0 | 0900006484763953 | |
| FDA-2008-N-0567-0169 | FDA | None FDA-2008-N-0567 | Notice of Decision Not To Designate Clonorchiasis as an Addition to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act | Notice | Designations | 2020-07-15T04:00:00Z | 2020 | 7 | 2020-07-15T04:00:00Z | 2020-07-15T13:52:03Z | 2020-15253 | 0 | 0 | 09000064847639d9 | |
| FDA-2008-N-0567-0168 | FDA | None FDA-2008-N-0567 | Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act | Notice | Notice of Final Rule | 2020-07-15T04:00:00Z | 2020 | 7 | 2020-07-15T04:00:00Z | 2020-07-15T13:42:40Z | 2020-15252 | 0 | 0 | 09000064847639a5 | |
| FDA-2008-N-0567-0170 | FDA | None FDA-2008-N-0567 | Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act | Notice | Notice of Final Rule | 2020-07-15T04:00:00Z | 2020 | 7 | 2020-07-15T04:00:00Z | 2020-07-15T14:07:24Z | 2020-15254 | 0 | 0 | 0900006484763a81 | |
| FDA-2008-N-0567-0055 | FDA | None FDA-2008-N-0567 | Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act | Notice | Notice of Final Rule | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T04:00:00Z | 2024-11-07T01:04:55Z | 2018-18314 | 1 | 0 | 090000648364f86f | |
| FDA-2008-N-0567-0081 | FDA | None FDA-2008-N-0567 | 002 Reference 1 - Chikungunya - epidemiology | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:56Z | 0 | 0 | 090000648365031a | |||
| FDA-2008-N-0567-0110 | FDA | None FDA-2008-N-0567 | 015 Reference 14 - Burden of Chikungunya in India - Estimates of DALY Lost in 2006 Epidemic | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:17Z | 0 | 0 | 09000064836505b0 | |||
| FDA-2008-N-0567-0111 | FDA | None FDA-2008-N-0567 | 014 Reference 13 - Morbidity and Impaired Quality of Life 30 Months After Chikungunya Infection | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:17Z | 0 | 0 | 0900006483650340 | |||
| FDA-2008-N-0567-0140 | FDA | None FDA-2008-N-0567 | 053 Reference 52 - Global Report UNAIDS Report on the Global AIDS Epidemic 2013 | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:39Z | 0 | 0 | 09000064836503cd | |||
| FDA-2008-N-0567-0091 | FDA | None FDA-2008-N-0567 | 028 Reference 27 - Predictors of Pneumocystis carinii pneumonia in HIV-infected persons | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:02Z | 0 | 0 | 0900006483650546 | |||
| FDA-2008-N-0567-0126 | FDA | None FDA-2008-N-0567 | 041 Reference 40 - Cost of Rabies Prevention | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:29Z | 0 | 0 | 0900006483650397 | |||
| FDA-2008-N-0567-0125 | FDA | None FDA-2008-N-0567 | 042 Reference 41 - Cryptococcosis- Epidemiology, Fungal Resistance, and New Alternatives for Treatment | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:29Z | 0 | 0 | 09000064836503be | |||
| FDA-2008-N-0567-0119 | FDA | None FDA-2008-N-0567 | 048 Reference 47 - The Changing Epidemiology of Cryptococcosis - An Update from Population-Based Active Surveillance in 2 Large Metropolitan Areas, 1992-2000 | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:25Z | 0 | 0 | 09000064836503c4 | |||
| FDA-2008-N-0567-0144 | FDA | None FDA-2008-N-0567 | 049 Reference 48 - Epidemiology of Cryptococcal Meningitis in the US | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:42Z | 0 | 0 | 09000064836503c5 | |||
| FDA-2008-N-0567-0057 | FDA | None FDA-2008-N-0567 | 020 Reference 19 - Burden of serious fungal infections in Tanzania | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:38Z | 0 | 0 | 0900006483650535 | |||
| FDA-2008-N-0567-0137 | FDA | None FDA-2008-N-0567 | 030 Reference 29 - Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:36Z | 0 | 0 | 09000064836505ff | |||
| FDA-2008-N-0567-0068 | FDA | None FDA-2008-N-0567 | 009 Reference 8 - Polymerase chain reactions for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:45Z | 0 | 0 | 09000064836500ff | |||
| FDA-2008-N-0567-0107 | FDA | None FDA-2008-N-0567 | 018 Reference 17 - Neglected Tropical Diseases | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:15Z | 0 | 0 | 09000064836505b3 | |||
| FDA-2008-N-0567-0074 | FDA | None FDA-2008-N-0567 | 003 Reference 2 - HIV Surveillance Report 2015 | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:49Z | 0 | 0 | 09000064836500f9 | |||
| FDA-2008-N-0567-0071 | FDA | None FDA-2008-N-0567 | 006 Reference 5 - Key Statistics for Acute Lymphocytic Leukemia | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:47Z | 0 | 0 | 09000064836500fc | |||
| FDA-2008-N-0567-0066 | FDA | None FDA-2008-N-0567 | 011 Reference 10 - AIDS-defining opportunistic illnesses in US patients | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:43Z | 0 | 0 | 09000064836502bd | |||
| FDA-2008-N-0567-0064 | FDA | None FDA-2008-N-0567 | 013 Reference 12 - Pneumocystis species | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:42Z | 0 | 0 | 09000064836502bf | |||
| FDA-2008-N-0567-0063 | FDA | None FDA-2008-N-0567 | 014 Reference 13 - Pneumocystic pneumonia CDC | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:42Z | 0 | 0 | 09000064836502c0 | |||
| FDA-2008-N-0567-0108 | FDA | None FDA-2008-N-0567 | 017 Reference 16 - Severe Manifestations of Chikungunya Virus in Critically Ill Patients During the 2013-2014 Caribbean Outbreak | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:15Z | 0 | 0 | 09000064836505b2 | |||
| FDA-2008-N-0567-0106 | FDA | None FDA-2008-N-0567 | 019 Reference 18 - Lymphocytic Choriomenengitis, Lassa Fever, and South American Hemorrhagic Fevers | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:14Z | 0 | 0 | 09000064836505b4 | |||
| FDA-2008-N-0567-0098 | FDA | None FDA-2008-N-0567 | 027 Reference 26 - Essential Medicines and Health Products - WHO Publishes List of Top Emerging Diseases Likely To Cause Major Epidemics | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:09Z | 0 | 0 | 09000064836505fc | |||
| FDA-2008-N-0567-0116 | FDA | None FDA-2008-N-0567 | 009 Reference 8 - Chikungunya 2015 Final Data for the United States | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:20Z | 0 | 0 | 0900006483650339 | |||
| FDA-2008-N-0567-0094 | FDA | None FDA-2008-N-0567 | 025 Reference 24 - Burden of serious fungal infections in Nepal | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:04Z | 0 | 0 | 090000648365053a | |||
| FDA-2008-N-0567-0090 | FDA | None FDA-2008-N-0567 | 029 Reference 28 - Burden of pneumocystis pneumonia in HIV-infected adults in sub-Saharan Africa | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:01Z | 0 | 0 | 0900006483650547 | |||
| FDA-2008-N-0567-0077 | FDA | None FDA-2008-N-0567 | 006 Reference 5 - Towards Antivirals Against Chikungunya Virus | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:53Z | 0 | 0 | 090000648365031e | |||
| FDA-2008-N-0567-0115 | FDA | None FDA-2008-N-0567 | 010 Reference 9 - Chikungunya | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:19Z | 0 | 0 | 090000648365033a | |||
| FDA-2008-N-0567-0123 | FDA | None FDA-2008-N-0567 | 044 Reference 43 - New Approaches to the Diagnosis and Treatment of Cryptococcal Meningitis | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:27Z | 0 | 0 | 09000064836503c0 | |||
| FDA-2008-N-0567-0122 | FDA | None FDA-2008-N-0567 | 045 Reference 44 - Clinical Practice Guidelines for the Management of Cryptococcal Disease | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:27Z | 0 | 0 | 09000064836503c1 | |||
| FDA-2008-N-0567-0120 | FDA | None FDA-2008-N-0567 | 047 Reference 46 - Estimation of the Current Global Burden of Cryptococcal Meningitis Among Persons Living with HIV AIDS | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:26Z | 0 | 0 | 09000064836503c3 | |||
| FDA-2008-N-0567-0097 | FDA | None FDA-2008-N-0567 | 022 Reference 21 - Cryptococcal disease and the burden of other fungal diseases in Uganda | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:06Z | 0 | 0 | 0900006483650537 | |||
| FDA-2008-N-0567-0062 | FDA | None FDA-2008-N-0567 | 015 Reference 14 - USPHS IDSA Guidelines for the Prevention of Opportunistic infections in Persons Infected with HIV | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:41Z | 0 | 0 | 09000064836502c1 | |||
| FDA-2008-N-0567-0078 | FDA | None FDA-2008-N-0567 | 005 Reference 4 - Persistent Arthralgia Associated With Chikungunya Virus | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:53Z | 0 | 0 | 090000648365031d | |||
| FDA-2008-N-0567-0136 | FDA | None FDA-2008-N-0567 | 031 Reference 30 - WHO Guide for Rabies Pre and Post Exposure Prophylaxis in Humans (updated 2014) | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:35Z | 0 | 0 | 0900006483650600 | |||
| FDA-2008-N-0567-0134 | FDA | None FDA-2008-N-0567 | 033 Reference 32 - Distribution of Risk Levels for Humans Contacting Rabies, | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:34Z | 0 | 0 | 0900006483650602 | |||
| FDA-2008-N-0567-0124 | FDA | None FDA-2008-N-0567 | 043 Reference 42 - C. neoformans Infection Statistics | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:28Z | 0 | 0 | 09000064836503bf | |||
| FDA-2008-N-0567-0087 | FDA | None FDA-2008-N-0567 | 032 Reference 31 - Risk Factors for Mortality from Acute Lower Respiratory Infections in Children under Five Years of Age in Low and Middle-Income Countries | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:59Z | 0 | 0 | 090000648365054a | |||
| FDA-2008-N-0567-0072 | FDA | None FDA-2008-N-0567 | 005 Reference 4 - Transplant Activity Report Total Transplants By Year | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:48Z | 0 | 0 | 09000064836500fb | |||
| FDA-2008-N-0567-0070 | FDA | None FDA-2008-N-0567 | 007 Reference 6 - Pneumocystis pneumonia associated with human immunodeficiency virus | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:46Z | 0 | 0 | 09000064836500fd | |||
| FDA-2008-N-0567-0065 | FDA | None FDA-2008-N-0567 | 012 Reference 11 - Increasing pneumocystis pneumonia England, UK, 2000-2010 | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:43Z | 0 | 0 | 09000064836502be | |||
| FDA-2008-N-0567-0118 | FDA | None FDA-2008-N-0567 | 007 Reference 6 - The Global Virus Network Challenging Chikungunya | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:21Z | 0 | 0 | 0900006483650323 | |||
| FDA-2008-N-0567-0117 | FDA | None FDA-2008-N-0567 | 008 Reference 7 - Why Arboviruses Can Be Neglected Tropical Diseases | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:20Z | 0 | 0 | 0900006483650337 | |||
| FDA-2008-N-0567-0058 | FDA | None FDA-2008-N-0567 | 019 Reference 18 - Burden of serious fungal infections in Belgium | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:39Z | 0 | 0 | 0900006483650534 | |||
| FDA-2008-N-0567-0096 | FDA | None FDA-2008-N-0567 | 023 Reference 22 - Estimating the burden of fungal disease in Vietnam | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:05Z | 0 | 0 | 0900006483650538 | |||
| FDA-2008-N-0567-0093 | FDA | None FDA-2008-N-0567 | 026 Reference 25 - Burden of serious fungal infections in Ukraine | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:03Z | 0 | 0 | 090000648365053b | |||
| FDA-2008-N-0567-0086 | FDA | None FDA-2008-N-0567 | 033 Reference 32 - Current epidemiology of Pneumocystis pneumonia | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:59Z | 0 | 0 | 090000648365054b | |||
| FDA-2008-N-0567-0073 | FDA | None FDA-2008-N-0567 | 004 Reference 3 - 2015 UNOS Annual Report | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:48Z | 0 | 0 | 09000064836500fa | |||
| FDA-2008-N-0567-0061 | FDA | None FDA-2008-N-0567 | 016 Reference 15 - The spectrum of clinical and pathological manifestations of AIDS in a consecutive serious of autopsied patients in Mexico | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:40Z | 0 | 0 | 09000064836502c2 | |||
| FDA-2008-N-0567-0104 | FDA | None FDA-2008-N-0567 | 021 Reference 20 - Acute Sensorineural Deafness in Lassa Fever | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:13Z | 0 | 0 | 09000064836505b6 | |||
| FDA-2008-N-0567-0103 | FDA | None FDA-2008-N-0567 | 022 Reference 21 - Lassa Fever Confirmed in Death of U.S. Traveler Returning from Liberia | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:12Z | 0 | 0 | 09000064836505b8 | |||
| FDA-2008-N-0567-0135 | FDA | None FDA-2008-N-0567 | 032 Reference 31 - WHO Expert Consultation on Rabies, 2nd Report, WHO Technical Report Series 982 Geneva | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:35Z | 0 | 0 | 0900006483650601 | |||
| FDA-2008-N-0567-0131 | FDA | None FDA-2008-N-0567 | 036 Reference 35 - Annual Estimates of the Resident Population April 1, 2010 to July 1, 2015 | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:32Z | 0 | 0 | 0900006483650390 | |||
| FDA-2008-N-0567-0129 | FDA | None FDA-2008-N-0567 | 038 Reference 37 - Facts about rabies | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:31Z | 0 | 0 | 0900006483650394 | |||
| FDA-2008-N-0567-0143 | FDA | None FDA-2008-N-0567 | 050 Reference 49 - Emergence of Cryptococcus gattii--Pacific Northwest, 2004-2010 | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:41Z | 0 | 0 | 09000064836503c6 | |||
| FDA-2008-N-0567-0089 | FDA | None FDA-2008-N-0567 | 030 Reference 29 - Pneumocystis carinii pneumonia in patients in the developing world who have AIDS | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:01Z | 0 | 0 | 0900006483650548 | |||
| FDA-2008-N-0567-0054 | FDA | None FDA-2008-N-0567 | Notice of Decision Not To Designate Pneumocystis Pneumonia as a Tropical Disease | Notice | General Notice | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T04:00:00Z | 2018-08-24T12:55:10Z | 2018-18313 | 0 | 0 | 090000648364f81d | |
| FDA-2008-N-0567-0132 | FDA | None FDA-2008-N-0567 | 035 Reference 34 - Epidemiology of Rabies Post-Exposure Prophylaxis--United States of America, 2006-2008 | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:33Z | 0 | 0 | 090000648365038f | |||
| FDA-2008-N-0567-0059 | FDA | None FDA-2008-N-0567 | 018 Reference 17 - Respiratory complications in Brazilian patients infected with HIV | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:39Z | 0 | 0 | 0900006483650533 | |||
| FDA-2008-N-0567-0076 | FDA | None FDA-2008-N-0567 | 001 Reference List | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:50Z | 0 | 0 | 09000064836500f7 | |||
| FDA-2008-N-0567-0079 | FDA | None FDA-2008-N-0567 | 004 Reference 3 - French Guidelines for the Management of Chikungunya | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:54Z | 0 | 0 | 090000648365031c | |||
| FDA-2008-N-0567-0105 | FDA | None FDA-2008-N-0567 | 020 Reference 19 - Imported Lassa Fever --- New Jersey, 2004 | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:13Z | 0 | 0 | 09000064836505b5 | |||
| FDA-2008-N-0567-0060 | FDA | None FDA-2008-N-0567 | 017 Reference 16 - Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok Thailand | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:40Z | 0 | 0 | 09000064836502c5 | |||
| FDA-2008-N-0567-0085 | FDA | None FDA-2008-N-0567 | 034 Reference 33 - Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:58Z | 0 | 0 | 090000648365054c | |||
| FDA-2008-N-0567-0083 | FDA | None FDA-2008-N-0567 | 036 Reference 35 - Neglected Tropical Diseases | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:57Z | 0 | 0 | 090000648365054e | |||
| FDA-2008-N-0567-0112 | FDA | None FDA-2008-N-0567 | 013 Reference 12 - Measuring the Burden of Arboviral Diseases The Spectrum of Morbidity and Mortality from Four Prevalent Infections | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:18Z | 0 | 0 | 090000648365033f | |||
| FDA-2008-N-0567-0133 | FDA | None FDA-2008-N-0567 | 034 Reference 33 - Rabies Surveillance in the United States During 2014 | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:33Z | 0 | 0 | 090000648365038e | |||
| FDA-2008-N-0567-0130 | FDA | None FDA-2008-N-0567 | 037 Reference 36 - Rabies Fact Sheet | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:32Z | 0 | 0 | 0900006483650393 | |||
| FDA-2008-N-0567-0095 | FDA | None FDA-2008-N-0567 | 024 Reference 23 - Burden of fungal infections in Senegal | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:04Z | 0 | 0 | 0900006483650539 | |||
| FDA-2008-N-0567-0080 | FDA | None FDA-2008-N-0567 | 003 Reference 2 - Seroprevalence of Chikungunya Virus Infection on Grande Comore Island, Union of the Comoros, 2005 2 | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:55Z | 0 | 0 | 090000648365031b | |||
| FDA-2008-N-0567-0102 | FDA | None FDA-2008-N-0567 | 023 Reference 22 - Public Health Assessment of Potential Biological Terrorism Agents | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:12Z | 0 | 0 | 09000064836505b9 | |||
| FDA-2008-N-0567-0101 | FDA | None FDA-2008-N-0567 | 024 Reference 23 - Hemorrhagic Fever Viruses as Biological Weapons | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:11Z | 0 | 0 | 09000064836505f9 | |||
| FDA-2008-N-0567-0099 | FDA | None FDA-2008-N-0567 | 026 Reference 25 - 2017-2018 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:10Z | 0 | 0 | 09000064836505fb | |||
| FDA-2008-N-0567-0128 | FDA | None FDA-2008-N-0567 | 039 Reference 38 - Expert Consultation on Rabies Post-Exposure Prophylaxis | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:30Z | 0 | 0 | 0900006483650395 | |||
| FDA-2008-N-0567-0127 | FDA | None FDA-2008-N-0567 | 040 Reference 39 - Immunizations and Chemoprophlaxis for the Prevention of Infectious Diseases | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:30Z | 0 | 0 | 0900006483650396 | |||
| FDA-2008-N-0567-0142 | FDA | None FDA-2008-N-0567 | 051 Reference 50 - Current Trends in the Prevalence of Cryptococcus Gattii in the United States and Canada | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:40Z | 0 | 0 | 09000064836503c7 | |||
| FDA-2008-N-0567-0056 | FDA | None FDA-2008-N-0567 | 021 Reference 20 - Bronchoscopy is useful for diagnosing smear-negative tuberculosis in HIV-infected patients | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:37Z | 0 | 0 | 0900006483650536 | |||
| FDA-2008-N-0567-0113 | FDA | None FDA-2008-N-0567 | 012 Reference 11 - Chikungunya Infection in DOD Healthcare Beneficiaries Following the 2013 Introduction of the Virus | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:18Z | 0 | 0 | 090000648365033e | |||
| FDA-2008-N-0567-0141 | FDA | None FDA-2008-N-0567 | 052 Reference 51 - Diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:40Z | 0 | 0 | 09000064836503cc | |||
| FDA-2008-N-0567-0067 | FDA | None FDA-2008-N-0567 | 010 Reference 9 - An estimateof the burden of serious fungal diseases in Greece | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:44Z | 0 | 0 | 0900006483650500 | |||
| FDA-2008-N-0567-0088 | FDA | None FDA-2008-N-0567 | 031 Reference 30 - Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:00Z | 0 | 0 | 0900006483650549 | |||
| FDA-2008-N-0567-0084 | FDA | None FDA-2008-N-0567 | 035 Reference 34 - Global Report UNAIDS report on the global AIDS epidemic 2013 | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:57Z | 0 | 0 | 090000648365054d | |||
| FDA-2008-N-0567-0109 | FDA | None FDA-2008-N-0567 | 016 Reference 15 - Measuring the Burden of Arboviral Diseases | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:16Z | 0 | 0 | 09000064836505b1 | |||
| FDA-2008-N-0567-0138 | FDA | None FDA-2008-N-0567 | 029 Reference 28 - Rhabdoviruses | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:36Z | 0 | 0 | 09000064836505fe | |||
| FDA-2008-N-0567-0082 | FDA | None FDA-2008-N-0567 | 001 Reference List | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:56Z | 0 | 0 | 090000648365054f | |||
| FDA-2008-N-0567-0100 | FDA | None FDA-2008-N-0567 | 025 Reference 24 - Zoonoses Likely to be Used in Bioterrorism | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:10Z | 0 | 0 | 09000064836505fa | |||
| FDA-2008-N-0567-0114 | FDA | None FDA-2008-N-0567 | 011 Reference 10 - Chikungunya Virus Geographic Distribution | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:19Z | 0 | 0 | 090000648365033c | |||
| FDA-2008-N-0567-0121 | FDA | None FDA-2008-N-0567 | 046 Reference 45 - A Prospective Longitudinal Study of the Clinical Outcomes from Cryptococcal Meningitis | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:26Z | 0 | 0 | 09000064836503c2 | |||
| FDA-2008-N-0567-0092 | FDA | None FDA-2008-N-0567 | 027 Reference 26 - Pneumocystis pneumonia in South African children with and without HIV infection in the era of HAART | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:02Z | 0 | 0 | 090000648365053c | |||
| FDA-2008-N-0567-0075 | FDA | None FDA-2008-N-0567 | 002 Reference 1 - Pneumocystis pneumonia | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:49Z | 0 | 0 | 09000064836500f8 | |||
| FDA-2008-N-0567-0069 | FDA | None FDA-2008-N-0567 | 008 Reference 7 - Current epidemiology of pneumocystis pneumonia | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:01:46Z | 0 | 0 | 09000064836500fe | |||
| FDA-2008-N-0567-0139 | FDA | None FDA-2008-N-0567 | 028 Reference 27 - 2017 Annual Review of Diseases Prioritized Under the Research and Development Blueprint | Supporting & Related Material | Background Material | 2018-08-24T04:00:00Z | 2018 | 8 | 2018-08-24T18:02:37Z | 0 | 0 | 09000064836505fd | |||
| FDA-2008-N-0567-0025 | FDA | None FDA-2008-N-0567 | Reference 13 - Marginalize re Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act | Supporting & Related Material | Background Material | 2015-08-20T04:00:00Z | 2015 | 8 | 2015-08-20T17:00:59Z | 0 | 0 | 0900006481c28cd7 | |||
| FDA-2008-N-0567-0028 | FDA | None FDA-2008-N-0567 | Reference 16 - Parasites--American Trypanosomiasis (also known as Chagas Disease) Detailed FAQs re Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act | Supporting & Related Material | Background Material | 2015-08-20T04:00:00Z | 2015 | 8 | 2015-08-20T17:01:18Z | 0 | 0 | 0900006481c28cda | |||
| FDA-2008-N-0567-0035 | FDA | None FDA-2008-N-0567 | Reference 23 - Neurocysticercosis A Disease of Neglect re Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act | Supporting & Related Material | Background Material | 2015-08-20T04:00:00Z | 2015 | 8 | 2015-08-20T17:02:05Z | 0 | 0 | 0900006481c28ce1 | |||
| FDA-2008-N-0567-0036 | FDA | None FDA-2008-N-0567 | Reference 24 - The Burden of Cysticercosis re Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act | Supporting & Related Material | Background Material | 2015-08-20T04:00:00Z | 2015 | 8 | 2015-08-20T17:02:13Z | 0 | 0 | 0900006481c28ce2 | |||
| FDA-2008-N-0567-0037 | FDA | None FDA-2008-N-0567 | Reference 25 - Neurocysticercosis in the United States Review of an Important Emerging Infection re Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act | Supporting & Related Material | Background Material | 2015-08-20T04:00:00Z | 2015 | 8 | 2015-08-20T17:02:19Z | 0 | 0 | 0900006481c28ce3 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;